These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6221511)

  • 1. Thromboxane synthase as a cytochrome P450 enzyme.
    Ullrich V; Haurand M
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():105-10. PubMed ID: 6221511
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets.
    Hammarström S; Falardeau P
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3691-5. PubMed ID: 410024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibitor of thromboxane synthetase: pyridine and its derivatives.
    Miyamoto T; Taniguchi K; Tanouchi T; Hirata F
    Adv Prostaglandin Thromboxane Res; 1980; 6():443-5. PubMed ID: 7189950
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
    Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
    Basevich VV; Mevkh AT; Varfolomeev SD
    Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of thromboxane synthetase inhibitors.
    Aiken JW
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():253-8. PubMed ID: 6221532
    [No Abstract]   [Full Text] [Related]  

  • 7. Localization of cyclo-oxygenase and thromboxane synthetase in human platelet intracellular membranes.
    Carey F; Menashi S; Crawford N
    Biochem J; 1982 Jun; 204(3):847-51. PubMed ID: 6812567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S; Wakitani K; Katsube N; Kawasaki A; Tsuboshima M; Naito J; Ujiie A; Komatsu H; Iizuka K
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():241-4. PubMed ID: 6221530
    [No Abstract]   [Full Text] [Related]  

  • 9. Calmodulin stimulates thromboxane synthesis in human platelets: studies with thromboxane synthetase inhibitors.
    Wong PY; Cheung WY
    Prog Lipid Res; 1981; 20():447-52. PubMed ID: 6804974
    [No Abstract]   [Full Text] [Related]  

  • 10. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial purification and assay of thromboxane A synthase from bovine platelets.
    Yoshimoto T; Yamamoto S
    Methods Enzymol; 1982; 86():106-9. PubMed ID: 6890138
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase.
    Diczfalusy U; Falardeau P; Hammarström S
    FEBS Lett; 1977 Dec; 84(2):271-4. PubMed ID: 598509
    [No Abstract]   [Full Text] [Related]  

  • 13. RS-5186, a novel, long-acting thromboxane synthetase inhibitor.
    Matsuda K; Ushiyama S; Ito T; Asai F; Oshima T; Ikeda T; Nakagawa A; Terada A; Yamazaki M
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():674-7. PubMed ID: 2526559
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzymatic synthesis of 15-hydroperoxythromboxane A2 and 12-hydroperoxy-5,8,10-heptadecatrienoic acid.
    Hammarström S
    J Biol Chem; 1980 Jan; 255(2):518-21. PubMed ID: 7356630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of cyclooxygenase induction in the biosynthesis of prostacyclin.
    Murota S; Chang WC; Koshihara Y; Morita I
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():99-104. PubMed ID: 6221583
    [No Abstract]   [Full Text] [Related]  

  • 16. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
    Aiken JW; Shebuski RJ; Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition by FCE 22178 of platelet and glomerular thromboxane synthase in animal and human kidney disease.
    Alessandrini P; Salvati P; Pugliese F; Ciabattoni G; Patrono C
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():707-10. PubMed ID: 1825400
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide modulates the activity of the hemoproteins prostaglandin I2 synthase and thromboxane A2 synthase.
    Wade ML; Fitzpatrick FA
    Arch Biochem Biophys; 1997 Nov; 347(2):174-80. PubMed ID: 9367522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and expression of human thromboxane synthase.
    Tanabe T; Yokoyama C; Miyata A; Ihara H; Kosaka T; Suzuki K; Nishikawa Y; Yoshimoto T; Yamamoto S; Nüsing R
    J Lipid Mediat; 1993; 6(1-3):139-44. PubMed ID: 8357980
    [No Abstract]   [Full Text] [Related]  

  • 20. Thromboxane synthetase inhibitors: design and synthesis of a novel series of omega-pyridylalkenoic acids.
    Terao S; Kato K; Ohkawa S; Terashita Z; Nishikawa K
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():315-7. PubMed ID: 2936112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.